Received Jun 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 3 | J32PB | IM / LA |
The patient came in with their house assistant seeking to get a Prevnar 20 vaccine and a Shingles vaccine. The Prevnar vaccine had been given previously so we informed them of that, however the shingles vaccination history was missed. A claim was run and approved and the vaccine was given. When looking through the patient history, it was discovered that the patient had already received two doses of Shingrix. The house manager was notified and told to watch for any issues with the third dose. There have been no reported adverse effects from the vaccine reported as of the writing of this summary. We will follow up over the next several days-weeks with the patient to ensure that no harmful side effects were experienced. If the patient has any additional symptoms we will notify VAERS immediately.